SCHEMBL2960910

SCHEMBL2960910

CCCCCCCCc1ccccc1[C]1C=Cc2ccccc21

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 1/20 0.50
NR1H3 Q13133 1/20 0.50
LIPG Q9Y5X9 1/20 0.47
SETD7 Q8WTS6 1/20 0.43
GPR3 P46089 1/20 0.40
CYSLTR2 Q9NS75 5/20 0.40
CYSLTR1 Q9Y271 5/20 0.40
PTPN1 P18031 1/20 0.39
TYR P14679 1/20 0.38
BID P55957 3/20 0.38
MCL1 Q07820 3/20 0.38
BCL2L1 Q07817 2/20 0.38
BAK1 Q16611 2/20 0.38
KAT8 Q9H7Z6 2/20 0.38
PPARG P37231 1/20 0.38
PPARA Q07869 1/20 0.38
EP300 Q09472 1/20 0.38
KAT2A Q92830 1/20 0.38
KAT2B Q92831 1/20 0.38
KAT5 Q92993 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2972873 1.00 NR1H2 (0.50) NR1H2NR1H3LIPGSETD7GPR3
SCHEMBL2964256 1.00 NR1H2 (0.50) NR1H2NR1H3LIPGSETD7GPR3
SCHEMBL2964831 1.00 NR1H2 (0.50) NR1H2NR1H3LIPGSETD7GPR3
SCHEMBL2964402 1.00 NR1H2 (0.50) NR1H2NR1H3LIPGSETD7GPR3
SCHEMBL2970777 0.98 NR1H2 (0.48) NR1H2NR1H3LIPGSETD7GPR3
SCHEMBL2973991 0.93 NR1H2 (0.42) NR1H2NR1H3LIPGSETD7GPR3
SCHEMBL216310 0.86 SETD7 (0.36) NR1H2NR1H3LIPGSETD7PTPN1
SCHEMBL8157124 0.80 LIPG (0.62) NR1H2NR1H3LIPGGPR3CYSLTR2
SCHEMBL9619382 0.80 LIPG (0.62) NR1H2NR1H3LIPGGPR3CYSLTR2
SCHEMBL196217 0.80 LIPG (0.62) NR1H2NR1H3LIPGGPR3CYSLTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7276567-B2 Heterocyclic substituted metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-10-02 US claimed
US-7763562-B2 Heteroatom bridged metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2010-07-27 US disclosed
US-7276567-B2 Heterocyclic substituted metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-10-02 US disclosed
US-20070135597-A1 Heteroatom bridged metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. 2007-06-14 US disclosed
US-7214747-B2 Phosphorus substituted metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-05-08 US disclosed
US-7214746-B2 Phosphorus bridged metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-05-08 US disclosed
US-20050261449-A1 Heterocyclic substituted metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENT INC. 2005-11-24 US disclosed
US-20050239981-A1 Phosphorus bridged metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. 2005-10-27 US disclosed
US-20050239980-A1 Phosphorus substituted metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. 2005-10-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050239981-A1 Phosphorus bridged metallocene compounds for olefin polymerization PYM1, ZNF207, POLL NR1H2 2038/4885NR1H3 1941/4885LIPG 3247/4885
US-20070135597-A1 Heteroatom bridged metallocene compounds for olefin polymerization AP2M1, AP1M1, PYM1 NR1H2 1227/4885NR1H3 1012/4885LIPG 3839/4885
US-20050239980-A1 Phosphorus substituted metallocene compounds for olefin polymerization CCRL2, ARL1, OSBP2 NR1H2 21/4885NR1H3 44/4885LIPG 4222/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.